Literature DB >> 27797359

Penile cancer: Welcome changes in disease management and remaining challenges.

Ben Ayres1, Nick Watkin1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27797359     DOI： 10.1038/nrurol.2016.204

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  7 in total

1.  Clinical trial strategy for penis cancer.

Authors:  Steve Nicholson; Oliver Kayes; Suks Minhas
Journal:  BJU Int       Date:  2014-05-22       Impact factor: 5.588

2.  15 Years of penile cancer management in the United States: An analysis of the use of partial penectomy for localized disease and chemotherapy in the metastatic setting.

Authors:  Matthew Mossanen; Sarah Holt; John L Gore; Daniel W Lin; Jonathan L Wright
Journal:  Urol Oncol       Date:  2016-08-02       Impact factor: 3.498

3.  EAU guidelines on penile cancer: 2014 update.

Authors:  Oliver W Hakenberg; Eva M Compérat; Suks Minhas; Andrea Necchi; Chris Protzel; Nick Watkin
Journal:  Eur Urol       Date:  2014-11-01       Impact factor: 20.096

4.  Recurrence patterns of squamous cell carcinoma of the penis: recommendations for follow-up based on a two-centre analysis of 700 patients.

Authors:  Joost A P Leijte; Peter Kirrander; Ninja Antonini; Torgny Windahl; Simon Horenblas
Journal:  Eur Urol       Date:  2008-04-15       Impact factor: 20.096

5.  Neoadjuvant taxane-based combination chemotherapy in patients with advanced penile cancer.

Authors:  Rosa S Djajadiningrat; Andries M Bergman; Erik van Werkhoven; Erik Vegt; Simon Horenblas
Journal:  Clin Genitourin Cancer       Date:  2014-06-08       Impact factor: 2.872

6.  Socioeconomic factors and penile cancer risk and mortality; a population-based study.

Authors:  Christian Torbrand; Annette Wigertz; Linda Drevin; Yasin Folkvaljon; Mats Lambe; Ulf Håkansson; Peter Kirrander
Journal:  BJU Int       Date:  2016-07-04       Impact factor: 5.588

7.  Phase II trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic penis cancer (CRUK/09/001).

Authors:  S Nicholson; E Hall; S J Harland; J D Chester; L Pickering; J Barber; T Elliott; A Thomson; S Burnett; C Cruickshank; B Carrington; R Waters; A Bahl
Journal:  Br J Cancer       Date:  2013-10-29       Impact factor: 7.640
  7 in total
  1 in total

1.  The Biomarker Potential of Caveolin-1 in Penile Cancer.

Authors:  Andrej Panic; Henning Reis; Alina Wittka; Christopher Darr; Boris Hadaschik; Verena Jendrossek; Diana Klein
Journal:  Front Oncol       Date:  2021-03-31       Impact factor: 6.244
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.